Volume 41, Issue 7 pp. 317-322

Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis

Helen M Buntain

Helen M Buntain

Department of Respiratory Medicine, Royal Children's Hospital

Search for more papers by this author
Ristan M Greer

Ristan M Greer

Department of Paediatrics and Child Health, University of Queensland

Search for more papers by this author
Joseph CH Wong

Corresponding Author

Joseph CH Wong

Department of Nuclear Medicine and Bone Densitometry, Royal Brisbane, Hospital

Dr Helen Buntain, Department of Respiratory Medicine, Level 3 Woolworths Building, Royal Children's Hospital, Herston, QLD 4029, Australia. Fax: +61 7 3356 7328; email: [email protected]

*Present address: Department of Nuclear Medicine, Wesley Hospital, Chasely Road, Auchenflower, Qld 4066, Australia.

Present address: Faculty of Health and Environmental Sciences, Auckland University of Technology, Private Bag 92006, Auckland 1020, New Zealand.

Search for more papers by this author
Philip J Schluter

Corresponding Author

Philip J Schluter

School of Population Health, University of Queensland

Dr Helen Buntain, Department of Respiratory Medicine, Level 3 Woolworths Building, Royal Children's Hospital, Herston, QLD 4029, Australia. Fax: +61 7 3356 7328; email: [email protected]

*Present address: Department of Nuclear Medicine, Wesley Hospital, Chasely Road, Auchenflower, Qld 4066, Australia.

Present address: Faculty of Health and Environmental Sciences, Auckland University of Technology, Private Bag 92006, Auckland 1020, New Zealand.

Search for more papers by this author
Jennifer Batch

Jennifer Batch

Department of Endocrinology, Royal Children's Hospital

Search for more papers by this author
Peter Lewindon

Peter Lewindon

Department of Gastroenterology and Hepatology, Royal Children's Hospital

Search for more papers by this author
Scott C Bell

Scott C Bell

Adult Cystic Fibrosis Unit, Department of Medicine, University of Queensland, The Prince Charles Hospital, Brisbane, Queensland, Australia

Search for more papers by this author
Claire E Wainwright

Claire E Wainwright

Department of Respiratory Medicine, Royal Children's Hospital

Search for more papers by this author
First published: 07 July 2005
Citations: 35

Abstract

Background:  Pubertal delay is thought to contribute to suboptimal peak bone mass acquisition in young people with cystic fibrosis (CF), leading to an increased fracture incidence. This study aims to compare pubertal development in young people with CF with that of a local healthy population and assess the influence it has on areal bone mineral density (aBMD).

Methods: Tanner stage, age of menarche, bone age (BA), sex hormone levels and aBMD were examined in 85 individuals with CF (aged 5.3–18.1 years, 39 females) and 100 local controls (5.6–17.9 years, 54 females).

Results: Tanner stage and age of menarche were not significantly different between controls and CF. Tanner stage-adjusted mean values for follicle stimulating hormone (FSH), luteinizing hormone (LH) and testosterone (T) were lower in males with CF (FSH: P = 0.004, LH: P = 0.01 and T: P = 0.002). Bone age was delayed in adolescents with CF compared to controls (chronological age–BA: controls = 0.13 years (SE = 0.16), CF = 0.95 years (SE = 0.22), P = 0.003). Areal bone mineral density (adjusted for age, sex, height and lean tissue mass) was not significantly different between CF and controls. Moderate negative correlations were found between delayed BA and weight (r = −0.41, P < 0.001) and height (r = −0.41, P < 0.001).

Conclusions: There was no evidence of clinical pubertal delay or low aBMD (adjusted for short stature and lean tissue mass) in young people with CF when compared with a local population, despite lower nutritional markers, height and weight and delayed skeletal maturation.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.